Skip to main content

Liquidia Corp

LQDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001819576

In the last 90 days, Liquidia Corp insiders filed 0 open-market purchases and 20 sales; 336 institutions reported holding it in 13F filings for Q2 2026, worth $5.78B in total; no superinvestor holds it.

Holders of 5% or more of LQDA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Liquidia Corp, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of LQDA
HolderLatest formStakeChangeFirst filedLatest filingFiling
Farallon Capital Partners, L.P.13G/A9.90%8.66M shares−0.05 ppfrom 9.95%Jul 11, 20253 filingsFeb 9, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Liquidia Corp, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on LQDA
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 9, 20268:56 AM ETFarallon Capital Partners, L.P.and 30 others13G/A9.90%8.66M shares−0.05 ppfrom 9.95%Dec 31, 2025SEC
Nov 12, 202512:15 PM ETFarallon Capital Partners, L.P.and 29 others13G/A9.95%8.57M shares+1.95 ppfrom 8.00%Sep 30, 2025SEC
Jul 11, 20256:32 PM ETFarallon Capital Partners, L.P.and 29 others13G8.00%6.83M sharesNewJul 7, 2025SEC
Feb 12, 20255:34 PM ETLegend Aggregator, LPand 1 other13G/A2.20%1.86M shares–Below 5%Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Liquidia Corp shares.

No Form 144 notices for Liquidia Corp are on file.